All In Biotech

Drug Trial Radar · NCT00002101

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

450

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
PharmaciaPfizer (PFE)
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the efficacy of clarithromycin/ethambutol with placebo or with rifabutin at two different doses in reducing colony-forming units (CFUs) by 2 or more logarithms in patients with Mycobacterium avium Complex bacteremia and maintaining this response until 16 weeks post-randomization. To assess survival and comparative tolerability among the three treatment regimens.

Conditions

  • Mycobacterium Avium-Intracellulare Infection
  • HIV Infections

Interventions

  • Ethambutol hydrochlorideDrug

  • ClarithromycinDrug

  • RifabutinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • McDowell Clinic

    Phoenix, Arizona

  • Maricopa Med Research Foundation

    Phoenix, Arizona

  • Bay Harbor Hosp

    Harbor City, California

  • Ctr for Special Immunology

    Irvine, California

  • Combat Group

    Los Angeles, California

  • Cedars Sinai Med Ctr

    Los Angeles, California

  • Highland Gen Hosp / San Francisco Gen Hosp

    Oakland, California

  • HIV Research Group

    San Diego, California

  • UCSD / Ctr for Special Immunology

    San Diego, California

  • Saint Francis Mem Hosp

    San Francisco, California

  • San Francisco Veterans Administration Med Ctr

    San Francisco, California

  • Sunnyvale Med Clinic

    Sunnyvale, California

  • George Washington Univ Med Ctr

    Washington D.C., District of Columbia

  • Veterans Administration Med Ctr

    Washington D.C., District of Columbia

  • Infectious Disease Consultants

    Altamonte Springs, Florida

  • TheraFirst Med Ctrs Inc

    Fort Lauderdale, Florida

  • Dr Frank Tornaka

    Fort Lauderdale, Florida

  • Gary Richmond MD

    Fort Lauderdale, Florida

  • Dr Nelson Zide

    Hollywood, Florida

  • Ctr for Special Immunology

    Miami Beach, Florida

  • Dr Barry Rodwick

    Safety Harbor, Florida

  • Bay Area AIDS Consortium

    Tampa, Florida

  • Infectious Disease Research Consortium of Georgia

    Atlanta, Georgia

  • Dr Daniel Berger

    Chicago, Illinois

  • Univ of Kansas School of Medicine

    Wichita, Kansas

  • Tulane Univ Med School

    New Orleans, Louisiana

  • Dr Arnold Markowitz

    Keego Harbor, Michigan

  • Univ of Nebraska Med Ctr / HIV Clinic

    Omaha, Nebraska

  • East Orange Veterans Administration Med Ctr

    East Orange, New Jersey

  • North Jersey Community Research Initiative

    Newark, New Jersey

  • Long Island Jewish Med Ctr

    New Hyde Park, New York

  • Chelsea Village Med Ctr / Saint Vincent's Hosp

    New York, New York

  • Community Health Network

    Rochester, New York

  • Nalle Clinic

    Charlotte, North Carolina

  • Polyclinic Med Ctr

    Harrisburg, Pennsylvania

  • Buckley Braffman Stern Med Associates

    Philadelphia, Pennsylvania

  • Charleston Veterans Administration Med Ctr

    Charleston, South Carolina

  • Dr Alfred F Burnside Jr

    Columbia, South Carolina

  • Central Texas Med Foundation

    Austin, Texas

  • Houston Veterans Administration Med Ctr

    Houston, Texas

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.